蛋白質檢測市場規模、佔有率和成長分析(按類型、產品類型、技術、應用、最終用戶和地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1899851

蛋白質檢測市場規模、佔有率和成長分析(按類型、產品類型、技術、應用、最終用戶和地區分類)-2026-2033年產業預測

Protein Assays Market Size, Share, and Growth Analysis, By Type (Dye-binding Assays, Copper-ion-based Assays), By Product (Reagents, Kits), By Technology, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,蛋白質檢測市場規模將達到 71.2 億美元,到 2025 年將達到 79.1 億美元,到 2033 年將達到 185 億美元,在預測期(2026-2033 年)內複合年成長率為 11.2%。

蛋白質檢測市場正經歷強勁成長,這主要得益於多種因素。對蛋白質體學研究的日益重視以及藥物研發的進步顯著推動了市場需求。此外,慢性病發病率的上升以及對精準診斷工具的需求也促進了市場擴張。高通量篩檢等技術創新提高了蛋白質定量分析的效率。然而,某些檢測方法的複雜性以及蛋白質系統固有的變異性等挑戰可能會阻礙市場成長。北美在全球蛋白質檢測市場中扮演著重要角色,佔據了相當大的市場佔有率,這得益於其完善的研發基礎設施和製藥行業的持續發展。

蛋白質檢測市場促進因素

蛋白質體學研究和藥物發現領域日益成長的興趣,推動了對準確且環境友善的蛋白質定量方法的需求。隨著製藥和生物技術行業的持續發展,對可靠的蛋白質檢測方法來評估藥物療效和安全性變得癒發重要。創新治療方法的研發以及確保研究結果高品質這一迫切需求,進一步強化了這一趨勢。因此,蛋白質檢測技術的進步對於滿足這些領域的需求至關重要,能夠確保研究人員擁有進行可靠蛋白質分析所需的工具。

蛋白質測定市場限制因素

蛋白質檢測市場的主要限制因素源於檢測標準化方面的困難以及蛋白質結構固有的變異性,這阻礙了普遍適用且準確的定量分析的實現。此外,一些陽性檢測方法的複雜性也限制了其廣泛應用,尤其是在需要簡單快速結果的環境中。這些挑戰為研究人員和生產商帶來了障礙,因此,開發更標準化、更易於使用且能滿足各種應用需求並確保結果一致可靠的檢測方法至關重要。應對這些挑戰對於蛋白質檢測方法在各個領域的發展和應用至關重要。

蛋白質測定市場趨勢

蛋白質檢測市場的一大趨勢是開發高通量、多重檢測系統,該系統能夠同時分析多種蛋白質,以滿足科學研究和臨床應用中對高效、全面的蛋白質譜分析日益成長的需求。隨著微流體和生物感測器等先進技術的興起,這一趨勢正在推動蛋白質檢測調查方法的創新,在提高靈敏度的同時,最大限度地減少所需的樣品量。這些進步正在改變蛋白質分析的格局,使檢測更有效率且便捷,最終促進蛋白質研究領域的成長與發展。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球蛋白質檢測市場規模(按類型和複合年成長率分類)(2026-2033 年)

  • 染料結合試驗
  • 基於銅離子的檢測​​方法
  • 基於試紙的檢測
  • 其他蛋白質測定

全球蛋白質檢測市場規模(按產品和複合年成長率分類)(2026-2033 年)

  • 試劑
  • 成套工具
  • 設備和配件

全球蛋白質檢測市場規模(依技術及複合年成長率分類)(2026-2033 年)

  • 基於吸光度的蛋白質測定
  • 比色蛋白質測定
  • 基於螢光的蛋白質檢測

全球蛋白質檢測市場規模(按應用領域及複合年成長率分類)(2026-2033 年)

  • 藥物發現與開發
  • 疾病診斷
  • 其他用途

全球蛋白質檢測市場規模(依最終用戶分類)及複合年成長率(2026-2033 年)

  • 製藥和生物技術公司
  • 醫院
  • 臨床檢查室
  • 學術機構
  • 其他最終用戶

全球蛋白質檢測市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Thermo Fisher Scientific Inc.(USA)
  • Bio-Rad Laboratories, Inc.(USA)
  • Merck KGaA(Germany)
  • Abcam plc(UK)
  • Agilent Technologies, Inc.(USA)
  • Danaher Corporation(USA)
  • Roche Holding AG(Switzerland)
  • Siemens Healthineers AG(Germany)
  • PerkinElmer, Inc.(USA)
  • Bio-Techne Corporation(USA)
  • Promega Corporation(USA)
  • Lonza Group Ltd.(Switzerland)
  • Cell Signaling Technology, Inc.(USA)
  • Fujifilm Wako Pure Chemical Corporation(Japan)
  • Enzo Biochem, Inc.(USA)
  • Randox Laboratories Ltd.(UK)
  • DiaSorin SpA(Italy)
  • Cayman Chemical Company(USA)
  • Abnova Corporation(Taiwan)

結論與建議

簡介目錄
Product Code: SQMIG35D2203

Protein Assays Market size was valued at USD 7.12 Billion in 2024 and is poised to grow from USD 7.91 Billion in 2025 to USD 18.5 Billion by 2033, growing at a CAGR of 11.2% during the forecast period (2026-2033).

The Protein Assays market is experiencing robust growth fueled by several factors. A rising focus on proteomics research and advancements in drug discovery are significantly driving demand. Additionally, the increasing incidence of chronic diseases and the need for precise diagnostic tools further contribute to market expansion. Innovations in technology, such as high-throughput screening methods, improve the efficiency of protein quantification processes. However, challenges arise from the complexities of certain assays and the variability inherent in protein systems, which may hinder growth. North America commands a substantial market share, largely due to a well-established research infrastructure and ongoing developments in the pharmaceutical sector, positioning it as a key player in the global Protein Assays landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Assays Market Segments Analysis

Global Protein Assays Market is segmented by Type, Product, Technology, Application, End User and region. Based on Type, the market is segmented into Dye-binding Assays, Copper-ion-based Assays, Test Strip-based Assays and Other Protein Assays. Based on Product, the market is segmented into Reagents, Kits and Instruments & Accessories. Based on Technology, the market is segmented into Absorbance-based Protein Assays, Colorimetric-based Protein Assays and Fluorescence-based Protein Assays. Based on Application, the market is segmented into Drug Discovery and Development, Disease Diagnosis and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals, Clinical Laboratories, Academic Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Assays Market

The rising focus on proteomics research and drug discovery is driving the demand for accurate and environmentally friendly protein quantification methods. As the pharmaceutical and biotechnology industries continue to grow, the necessity for dependable protein assays to evaluate drug efficacy and safety becomes increasingly critical. This need is fueled by the development of innovative therapeutic approaches and the urgency to ensure high-quality results in research. Consequently, advancements in protein assay technologies are essential to meet the demands of these sectors, ensuring that researchers have the tools required for reliable protein analysis in their work.

Restraints in the Protein Assays Market

A significant constraint in the Protein Assays market arises from the difficulties linked to assay standardization and the inherent variability in protein structures, which hinder the achievement of universally applicable and accurate quantification. Additionally, the intricate nature of some positive assays can limit their widespread adoption, particularly in environments where simplicity and rapid results are essential. These challenges create barriers for researchers and manufacturers, making it crucial to develop more standardized and user-friendly assays that accommodate diverse applications while ensuring consistent and reliable outcomes. Addressing these issues is vital for the growth and acceptance of protein assays in various sectors.

Market Trends of the Protein Assays Market

The Protein Assays market is witnessing a significant trend towards the development of high-throughput and multiplexed assay systems that enable the simultaneous analysis of multiple proteins, catering to the increasing demand for efficiency and comprehensive protein profiling across research and clinical applications. Coupled with the rise of cutting-edge technologies such as microfluidics and biosensors, this trend drives innovation in protein assay methodologies, enhancing sensitivity while minimizing sample volume requirements. These advancements are reshaping the landscape of protein analysis, making assays more streamlined and accessible, ultimately fostering growth and expansion within the protein research community.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Protein Assays Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Dye-binding Assays
  • Copper-ion-based Assays
  • Test Strip-based Assays
  • Other Protein Assays

Global Protein Assays Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Reagents
  • Kits
  • Instruments & Accessories

Global Protein Assays Market Size by Technology & CAGR (2026-2033)

  • Market Overview
  • Absorbance-based Protein Assays
  • Colorimetric-based Protein Assays
  • Fluorescence-based Protein Assays

Global Protein Assays Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Drug Discovery and Development
  • Disease Diagnosis
  • Other Applications

Global Protein Assays Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Hospitals
  • Clinical Laboratories
  • Academic Institutes
  • Other End Users

Global Protein Assays Market Size & CAGR (2026-2033)

  • North America (Type, Product, Technology, Application, End User)
    • US
    • Canada
  • Europe (Type, Product, Technology, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Product, Technology, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Product, Technology, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Product, Technology, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abcam plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cell Signaling Technology, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Wako Pure Chemical Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzo Biochem, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cayman Chemical Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abnova Corporation (Taiwan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations